EichorEICHOR
Location: Bentonville Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Bentonville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Pillar Clinical Research - Richardson · Bristol-Myers Squibb · NCT06929273Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Phase 2 · Pillar Clinical Research LLC · Novartis Pharmaceuticals · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3 · Pillar Clinical Research · LB Pharmaceuticals Inc. · NCT07363577A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Pillar Clinical Research - Bentonville · Bristol-Myers Squibb · NCT07140913Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Phase 3 · Reviva site · Reviva Pharmaceuticals · NCT05184335A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Pillar Clinical Research LLC - Bentonville Site · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Phase 2 · Pillar Clinical Research · LB Pharmaceuticals Inc. · NCT07494305A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Phase 3 · Pillar Clinical Research · Xenon Pharmaceuticals Inc. · NCT07076407Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Phase 3 · Pillar Clinical Research · Rapport Therapeutics Inc. · NCT07594119A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Ep
Phase 3 · Pillar Clinical Research /ID# 226504 · AbbVie · NCT0477735752-week Open Label Safety-Tolerability Study
Phase 3 · Pillar Clinical Research · LB Pharmaceuticals Inc. · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · Local Institution - 0058 · Bristol-Myers Squibb · NCT06951698A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Phase 2 · Draig Clinical Site · Draig Therapeutics Ltd · NCT07300969
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.